Analysis
The new cyber security standard that will replace all others
The US Department of Defense (DoD) is implementing a new Cybersecurity Maturity Model Certification (CMMC) requirement for all private-sector businesses that work with the DoD.
Kiersten Archer
Director
Kiersten Archer is a Director within Controls Risks’ Compliance, Forensics and Intelligence practice in the Americas region. She has significant experience in corporate compliance, fraud and anti-corruption matters.
- Americas
- Corruption Risk Assessment & Analysis
- Cross Border Investigations
- Government-Mandated Monitorships
Kiersten Archer is a Director within Controls Risks’ Compliance, Forensics and Intelligence practice in the Americas region. She has significant experience in corporate compliance, fraud and anti-corruption matters.
Kiersten specializes in bribery and fraud investigations, compliance risk assessments and development of best-practice anti-corruption compliance programs. Her experience in matters involving violations of the US Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act includes global financial and forensic accounting investigations with suspected violations by US corporations or their international operating divisions, agents or distributors. She has also worked on global risk assessments, SEC and DOJ enforcement-driven investigations, and monitorships in numerous global jurisdictions.
In 2019, Control Risks’ Regulatory Risks and Investigations Team in the Americas, which Kiersten is a part of, was named Compliance Consulting Team of the Year at the C5 Women in Compliance Awards.
Kiersten’s recent experience includes:
- Participation in global on-site anti-corruption investigations and risk assessments for medical devices, pharmaceutical and dental implant companies, including focused transactional testing and data analytics to determine FCPA corruption risk.
- Assisted clients with global compliance program gap analyses and remediation, including development of corruption risk profiles.
- In a large financial institution securities litigation matter, assisted in responding to allegations that senior management issued materially false and misleading financial reports, artificially inflating the price of the entity’s securities.
- Participated in a complex independent investigation into a leading pharmaceutical company’s operations and interactions with healthcare professionals, distributors and vendors in China.Played a key role on a court-appointed independent compliance consulting team for a large global pharmaceutical company in connection with an FCPA settlement with the SEC.
Prior to joining Control Risks, Kiersten spent a decade at FTI Consulting where she was a senior director in its forensic and litigation consulting practice focusing on anti-corruption compliance and investigations.
Related articles
Analysis
Transitioning from CFIUS pilot program to full FIRRMA implementation
With final rules expected in early 2020, John Lash, Principal, Control Risks, discusses transitioning from the CFIUS pilot program to full Foreign Investment Risk Review Modernization Act (FIRMMA) implementation with Financiar Worlwide Magazine and a panel of experts.
Analysis
Adopting a resilient approach for recall management
Companies should take a holistic approach to product recall management, that focuses on managing the risk before, during and after a recall event.
Video
Hurricane Dorian in the Bahamas
Hurricane Dorian hit the Bahamas as a Category 5 hurricane on September 1st. Dorian remained stationary for 40 hours, causing widespread damage in Abaco and Grand Bahama.
Analysis
Business continuity planning for a modern workforce
To ensure the wellbeing of staff and avoid operational disruptions, business continuity planners must account for the full range of goods and services their personnel could lose access to in the event of a natural disaster.